Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French STEM Today.
Press releases published on July 29, 2025
Tellabs and Connectix Collaborate to Accelerate Passive Optical LAN Deployment Across the UK
EIN Presswire
·
July 29, 2025
UK’s First Center of Excellence for POL Announced CARROLLTON, TX, UNITED STATES, July 29, 2025 /EINPresswire.com/ -- Connectix Cabling Systems and Tellabs are proud to announce a new strategic partnership aimed at advancing the adoption of Passive …
DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report
GlobeNewswire
·
July 29, 2025
Châtillon, France, July 29, 2025 DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage …
DBV Technologies publie son Rapport Financier Semestriel 2025 ― Modalités de mise à disposition ou de consultation
GlobeNewswire
·
July 29, 2025
Châtillon, France, le 29 juillet 2025 DBV Technologies publie son Rapport Financier Semestriel 2025 ― Modalités de mise à disposition ou de consultation DBV Technologies (Euronext : DBV – ISIN : FR0010417345 - Nasdaq : DBVT), une société biopharmaceutique …
DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results
GlobeNewswire
·
July 29, 2025
Châtillon, France, July 29, 2025 DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company, …
DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2025
GlobeNewswire
·
July 29, 2025
Châtillon, France, le 29 juillet 2025 DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2025 DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock Market : DBVT-CUSIP : 23306J309), société biopharmaceutique …
ABL Diagnostics to Become Exclusive Distributor of VELADX in EMEA for Molecular Diagnostics
EIN Presswire
·
July 29, 2025
WOIPPY, FRANCE, July 29, 2025 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce the signing of an exclusive distribution agreement with VELA Operations …